Scientific Workshop on Germline Predisposition to Hematopoietic Malignancies and Bone Marrow Failure
Program: Scientific Workshops
Session: How Scientific Advances Impact Clinical Predictive Models and Recommendations
Program: Scientific Workshops
Session: How Scientific Advances Impact Clinical Predictive Models and Recommendations
Friday, December 8, 2023, 4:18 PM-4:59 PM
Disclosures: Salmenniemi: Viatris: Consultancy; Takeda: Membership on an entity's Board of Directors or advisory committees; Immedia Pharma AB: Membership on an entity's Board of Directors or advisory committees; Astra Zeneca: Membership on an entity's Board of Directors or advisory committees.